IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

226 hedge funds and large institutions have $970M invested in Iovance Biotherapeutics in 2023 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 106 increasing their positions, 52 reducing their positions, and 31 closing their positions.

Holders
226
Holders Change
+8
Holders Change %
+3.67%
% of All Funds
3.6%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
41
Increased
106
Reduced
52
Closed
31
Calls
$33.7M
Puts
$16.2M
Net Calls
+$17.4M
Net Calls Change
+$12.4M

Top Buyers

1
MFM
1
MHR Fund Management
New York
$91M
2
Millennium Management
2
Millennium Management
New York
$35.6M
3
State Street
3
State Street
Massachusetts
$76.1M
4
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$20.4M
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$18.1M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$6.43M
2
Sumitomo Mitsui Trust Group
2
Sumitomo Mitsui Trust Group
Japan
$0
3
NAMA
3
Nikko Asset Management Americas
New York
$0
4
Deutsche Bank
4
Deutsche Bank
Germany
$2.29M
5
PA
5
Perceptive Advisors
New York
$54.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
IA
251
IFP Advisors
Florida
– -$2.11K -300 Closed
MPWT
252
MassMutual Private Wealth & Trust
Connecticut
– -$1.63K -231 Closed
EWA
253
EverSource Wealth Advisors
Alabama
– -$1.61K -228 Closed
AF
254
Allworth Financial
California
– -$444 -63 Closed
7 8 9 10
11